Corrigendum: Guanxin Danshen formulation protects against myocardial ischemia reperfusion injury-induced left ventricular remodeling by upregulating estrogen receptor β

Xuehong Deng,Xiaoyan Xing,Guibo Sun,Xudong Xu,Haifeng Wu,Guang Li,Xiaobo Sun
DOI: https://doi.org/10.3389/fphar.2024.1488968
IF: 5.6
2024-10-09
Frontiers in Pharmacology
Abstract:This article is a correction to: Guanxin Danshen Formulation Protects against Myocardial Ischemia Reperfusion Injury-Induced Left Ventricular Remodeling by Upregulating Estrogen Receptor β
pharmacology & pharmacy
What problem does this paper attempt to address?